
MOTS-c
Mitochondrial-derived peptide studied in AMPK and metabolic homeostasis research.
- Purity:
- ≥99% HPLC
- Format:
- Vial — 2 sizes
Starting at
ARS 206,610
For laboratory research use only. Not for human or veterinary consumption.
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
Retatrutide is a synthetic triple receptor agonist studied for its simultaneous activity at the GLP-1, GIP and glucagon receptors. In published preclinical and clinical literature it is investigated in the context of energy balance, insulin sensitivity and satiety signalling pathways. Supplied as lyophilised powder for reconstitution in a laboratory setting.
The CoA for your specific batch is included with dispatch and available on request before purchase.
Request this batch CoAWe currently supply lyophilised powder in sealed vials, which is the most stable format for transit and long-term storage. Pre-filled pen devices are in development but not yet stocked — you can join the waitlist to be notified.
Yes, for every batch. Your CoA includes the HPLC chromatogram and mass spectrometry identity confirmation from an independent testing laboratory, matched to the batch number printed on your vial. We will also send a current CoA before you order if you ask.
Lyophilised vials should be stored at -20 °C and protected from light. Unopened, they remain within specification for 24 months. Reconstituted material should be refrigerated at 2–8 °C and used within the window indicated on your CoA.
You select a compound and vial size, then choose a 3- or 6-month cadence. We dispatch once per month at a locked-in unit price, with priority allocation from each new batch. You can pause or cancel before any upcoming dispatch.
All products on this site are sold strictly as laboratory reference materials. They are not drugs, not dietary supplements, and not intended for human or animal consumption, diagnosis, treatment, or any in-vivo application.
Compliance →
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
Billed monthly
ARS 131,881/mo
Total over 3 months: ARS 395,643
No payment required. No account needed. One business day response.
Pause or cancel any time before your next dispatch.

Mitochondrial-derived peptide studied in AMPK and metabolic homeostasis research.
Starting at
ARS 206,610

Growth hormone-releasing hormone analogue used in endocrine signalling research.
Starting at
ARS 112,326

Copper-binding tripeptide studied in extracellular matrix and dermal research models.
Starting at
ARS 149,865